Showing 9981-9990 of 20874 results for "".
Influence of Advertising on Children
https://reachmd.com/programs/clinicians-roundtable/influence-of-advertising-on-children/37/Dr. Strasburger identifies advertising trends in the media and the effect these trends ultimately have on children's health.Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study
https://reachmd.com/programs/Audioabstracts/predictors-emergency-department-use-persons-with-inflammatory-bowel-diseases-population-based-study/8566/Identified predictors of ED attendance and post-ED hospitalization could guide the optimization of outpatient IBD care.Why Participating in Improvement Activities Matters
https://reachmd.com/programs/perspectives-ama/why-participating-improvement-activities-matters/8366/An overview of the Improvement Activities, category, including how the activities may be reported and scored by CMS.Innovations in IgAN Care: Examining the Evolving Treatment Landscape
https://reachmd.com/programs/frontlines-iga-nephropathy/innovations-in-igan-care-examining-the-evolving-treatment-landscape/26941/Tune in to hear about the latest treatment advancements in IgA nephropathy.ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
https://reachmd.com/programs/frontlines-copd/ecg-markers-as-predictors-of-adverse-outcomes-in-copd-insights-from-the-impact-trial/35536/A post hoc analysis of the IMPACT trial evaluated two electrocardiographic biomarkers—CIIS and P pulmonale—as predictors of mortality, hospitalizations, and exacerbations in patients with chronic obstructive pulmonary disease (COPD). According to the findings, both biomarkers were linked with increaOvercoming Clinical Inertia to Individualize Myelofibrosis Treatment
https://reachmd.com/programs/project-oncology/individualizing-myelofibrosis-treatment/59183/As the treatment landscape for myelofibrosis continues to evolve, timely and individualized decision-making is essential to improving patient outcomes. That’s why Dr. Prithviraj Bose joins Dr. Alexandria May to explore how clinicians can overcome clinical inertia by initiating appropriate therapy eaUnderstanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses
https://reachmd.com/programs/dermconsult/il-36-signaling-gpp-neutrophilic-dermatoses/56721/What role does IL-36 signaling play in generalized pustular psoriasis (GPP) and why is it an emerging focus in neutrophilic inflammatory disease? Join Dr. Charles Turck and Dr. David Cotter, a dermatologist at Las Vegas Dermatology, as they explore the genetic and acquired mechanisms underlying IL-3Setting Expectations on IUD Expulsion Among Patients with Heavy Menstrual Bleeding
https://reachmd.com/programs/advances-in-womens-health/setting-expectations-on-iud-expulsion-among-patients-with-heavy-menstrual-bleeding/15457/Explore the importance of counseling patients with heavy menstrual bleeding about their increased risk of IUD expulsion.Redefining Mucosal Healing in IBD: Updated Goals of Therapy
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/redefining-mucosal-healing-in-ibd-updated-goals-therapy/8474/Dr. Lea Ann Chen and Dr. Hans Herfarth discuss updated goals of therapy for IBD based on novel understandings of mucosal healing.Reprogramming the Digestive System: Where Traditional and Integrative Therapies Merge
https://reachmd.com/programs/everyday-family-medicine/reprogramming-the-digestive-system-where-traditional-and-integrative-therapies-merge/7631/Dr. Jennifer Caudle welcomes Dr. Taz Bhatia, associate professor in Integrative Medicine at Emory University School of Medicine and and Founder and Medical Director of the Atlanta Center for Holistic and Integrative Medicine. Dr. Bhatia is author of The 21-Day Belly Fix: The Doctor-Designed Diet Pla